Serge Belanger
Stock Analyst at Needham
(1.6)
# 1246
Out of 5,296 analysts
391
Total ratings
48.65%
Success rate
11.56%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HRTX Heron Therapeutics | Reiterates: Buy | 4 4 | 2.27 | 76.21% | 22 | Apr 11, 2025 | |
BCRX BioCryst Pharma | Reiterates: Buy | 15 15 | 8.22 | 82.48% | 12 | Apr 10, 2025 | |
LQDA Liquidia | Reiterates: Buy | 25 25 | 14.03 | 78.19% | 28 | Apr 10, 2025 | |
AMPH Amphastar Pharma | Reiterates: Hold | n/a | n/a | n/a | 5 | Apr 10, 2025 | |
COLL Collegium Pharmaceut... | Reiterates: Buy | 46 46 | 26.89 | 71.07% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 14.73 | 35.78% | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 18 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 22 22 | 11.56 | 90.31% | 14 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 9.12 | 31.58% | 16 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 0.85 | 370.59% | 14 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 42 42 | 17.52 | 139.73% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 26.02 | 22.98% | 27 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 24 | 6.35 | 277.95% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 72 72 | 40.35 | 78.44% | 21 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.88 | 468.18% | 18 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 28 | 12.88 | 117.39% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 7.91 | 89.63% | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 62 66 | 39.55 | 66.88% | 11 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 21 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 13.55 | 180.44% | 15 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 38.23 | 56.94% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 8 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 5 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jul 1, 2020 |